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T h es pe ct r u mo fβ-thalassemia mutations
in the Arab populations
Laila Zahed†
Department of Pathology and Laboratory Medicine, American University of Beirut, Beirut, Lebanon
The Arab countries encompass a wide region stretching from the Persian Gulf to the Atlantic Ocean. The Arab population is
quite heterogeneous and has experienced various invasions and migrations throughout history. β-thalassemia is endemic in all
countries of the Arab world. Our review of the molecular basis of β-thalassemia in various Arab countries reveals the presence of
52 mutations, which are mostly of Mediterranean and Asian origin. The distribution of mutations reﬂects the geographical and
historical backgrounds of each region. However, no speciﬁc mutation is conﬁned to the Arabs, although some Arab countries do
have unique mutations.
INTRODUCTION
The Arab world is composed of 21 countries stretching
from the Persian Gulf to the Atlantic Ocean. Although Arab
people share a common history and culture, they are quite
heterogeneousinorigin,afactthatshouldbereﬂectedintheir
geneticbackground.β-thalassemiaisendemicinallcountries
of the Arab world, probably due to the presence of malaria
previously in that region,and the frequency of carriers varies
from 1% to 5%. The molecular basis of β-thalassemia has
been studied in various Arab countries and we present here
a review of those ﬁndings, in an attempt to compare the fre-
quency and origin of the different mutations.
REVIEW OFTHE LITERATURE
Various papers reporting the spectrum of β-thalassemia
mutations in different Arab countries have been published.
While detailed information about many populations is avail-
able, data for some countries is still lacking or only prelim-
inary. In some cases, the studies may be too small or too
speciﬁc to represent the entire country. Still, as much of the
currently available data have been collected and pooled and
the reported mutations and their corresponding frequencies
intwelvedifferentcountrieshavebeentabulatedforcompar-
ison (see Table 1). These include Syria [1], Lebanon [2–4],
Jordan[5],IsraeliArabs[6]andArabsfromtheGazastrip[7],
Saudi-Arabia [8–11], Kuwait [12], Bahrain [13], the United
Arab Emirates (UAE) [14–17], Oman [18], Egypt [19–23],
Tunisia [24, 25], and Algeria [26–28].
Arab countries from which data was not available in-
cluded Djibouti, Iraq, Mauritania, Morocco, Qatar, Soma-
lia, and Sudan. The data found on nationals from Lybia
or Yemen, as part of larger studies, was based on a small
number of patients in which only 2 or 3 of the most
common Mediterranean mutations were detected. Since this
was thought not to be clearly representative of the popula-
tion of each of these countries, the data was omitted from
this study.
RESULTS
A total of 52 mutations have been reported in the Arab
world, reﬂecting the heterogeneity of its population. As ex-
pected, each country has its own characteristic spectrum of
mutations, with a handful of frequent mutations and several
rare ones. The number and frequency of different mutations
varies from one country to another, depending on the stud-
ies and size of the population: total numbers reported so far
vary from 9 in Kuwait to 21 in Egypt.While some mutations
appear in most countries, others seem to be speciﬁc to a re-
gion or even a country. Several observations can be made,
discussed here below.
(1)ThecommonMediterraneanmutationsweredetected
in nearly all Arab countries, albeit at different frequencies.
Codon 39 (C>T), the most frequent mutation in the west-
ern Mediterranean region, was found in all Arab countries
withoutexception.Asexpected,itisfoundathigherfrequen-
cies in more western Arab countries, such as Tunisia and
Algeria (27% in both),whereas eastern countries show much
lower frequencies (down to 0.5% in Lebanon). Surprisingly,
it also reaches high frequencies in some southeastern non-
Mediterranean countries, such as Saudi Arabia (20%) and
Bahrain (24%). IVSI-110 (G>A) is the most common mu-
tation in the eastern Mediterranean. It has high frequencies
inallMediterraneanArabcountries(12%–38%),butreaches
lowerfrequenciesincountriesaroundtheGulf(0%–2%).The
same is true for IVSI-1 (G>A) and IVSI-6 (T>C), two other
frequentMediterraneanmutations.Ontheotherhand,IVSII-
1( G >A),was detected in all countries except Tunisia andAl-
geria, has a high frequency in North Jordan (20%) and is the130 Laila Zahed 1:3 (2001)
Table 1: Comparison of mutation frequencies among 13Arab populations. (S = Syria,L = Lebanon,J = Jordan,IA = IsraeliArabs,G = Gaza
strip, SA = Saudi Arabia, K = Kuwait, B = Bahrein, UAE = United Arab Emirates, O = Oman, E = Egypt, T = Tunisia,A = Algeria.)
Mutation Origin S L J IA G SA K B UAE O E T A
IVSI-110 (G>A) East Med 24 33 22 26.43 7 .52 2 — 1.51 .70 .53 3 1 2 .32 4 .7
IVSI-1 (G>A) Med 17 15 6.682 077 .33— 11 1 .30 .91 1 .7
Cd5( −CT) Med 8.54 3 .30 .64 10 ——— 40 .52 .41 .8 —
−30 (T>A) Turkish 70 .5 — 0.64 ———————2.60 .4
Cd39 (C>T) West Med 6.40 .52 81 1 .52 0 7 .32 4 .25 1 1 .52 7 2 7 .6
IVSI-6 (T>C) West Med 41 56 .61 4 .77 .577 .3 — 3.5 — 13.66 3 .3
IVSII-1 (G>A) Med 41 0 1 9 .87 1 1 52 96 .13 .33 .53——
Cd15 (G>A) Asian-Ind 3.5 ——0.64 ———1.51 .50 .5 ———
−88 (C>T) Asian-Ind 21 .5 ———————————
−87 (C>G) Med 21 .52 ———————1.2 ——
IVSI-116 (T>G) Med 1.4 — ———————————
IVSII-745 (C>G) Med 1.4 1 12 6 ——————5.64 .40 .9
Cd8/9 (+G) Asian-Ind 1.40 .5 ———2.51 .31 .57— 0.3 ——
Cd37 (G>A) Saud,Egypt 1.4 — 8.87 .41——— 1 — 0.6 ——
Cd8( −AA) Turkish 0.72 .5 — 6 — 10 3 — 4 — 1.80 .9 —
25bp deletion Asian-Ind 0.71 ———14 7.33 6 8 5 .5 ———
Cd29 (C>T) Lebanese — 7 ———————————
Cd30 (G>C) UAE — 3 —————— 3 ————
290bp deletion Turk, Iran — 2 ———————————
Cd44 (−C) Kurdish — 1 ———7.514 .51 .39 .6 — 4.4 —
IVSI-5 (G>C) Asian-Ind — 0.55 .52 .6 — 10 18.81 6 .75 56 1 .6 ——0.4
Cd27 (G>T) Med — — 3.3 — 1 —————0.30 .90 .4
IVSII-848 (C>A )E g y p t i a n — —2 —————0.5 — 8.60 .90 .4
Cd6( −A) Med — — 1 — 57 ———— 11 0 .51 7
IVSII-3’ (C>A) Black — — — 0.32 —————————
AATAAA>AA r a b — — — — 2.5 ————————
IVSI-5 (G>T ) M e d — — ——— 2 ———————
Cap +1 (A>C) Asian-Ind — — — — — 1 ————0.6 ——
Cd36/37 (−T ) K u r d , I r a n— — ——— 11.5 ——0.41———
−88 (C>A) Kurdish — — —————1.5 ——0.6 ——
Cd35 (−C) Indonesian — — —————1.5 —————
Cd41/42 (−TCTT) Asian-Ind — — —————1.5 —————
Cd82/83 (−G) Azerbaijian — — —————— 1 ————
Cd37 (−G) Kurdish — — —————— 10 .5 ———
AATAAA>AATAAG Kurdish — — ——————0.8 ————
Cd110 (T>C) Japanese — — ——————0.8 ————
−101 (C>T) Turkish — — ——————0.8 ————
Cd30 (AGG>AGC) various — — ——————0.4 ————
Cd30 (G>A ) B u l g a r i a n— — ———————0.5 — 2.60 .9
Hb Dofar Omani — — ———————6.6 ———
619bp deletion Indian — — ——————— 4 ———
HbE Asian-Ind — — ———————0.5 ———
Cd29 (−G) Japanese — — ————————1.2 ——
Cd106/107 (+G )B l a c k — — ————————0.6 ——
Cd28 (−C ) E g y p t — — ————————0.3 ——
Cd25/26 (+T) Tunisian — — —————————0.9 —
IVSI-2 (T>A ) A l g e r i a n — — —————————0.91 .3
IVSI-5 (G>A ) A l g e r i a n — — —————————0.90 .9
−29 (A>C ) B l a c k — — ——————————3.8
IVSI-2 (T>C ) B l a c k — — ——————————3.3
IVSII-843 (T>G ) A l g e r i a n — — ——————————0.4
Total mutations 16 18 13 13 10 14 9 12 21 15 19 16 161:3 (2001) β-thalassemia mutations in Arabs 131
most common mutation in Kuwait (29%) .C o d o n5( −CT),
a Mediterranean mutation of lower frequency, was found in
allArabMediterraneancountries,exceptAlgeria,whileitwas
not detected in most countries of the Arabian Peninsula.
(2)TheG>CsubstitutionatIVSI-5,amutationof Asian-
Indian origin, is the most common mutation in the UAE
(55%) and Oman (62%), and is quite frequent in neighbor-
ing Kuwait and Saudi Arabia (17%–19%). It is also found in
the majority of other Arab countries, although its frequency
diminishes appreciably in countries of Northern Africa.
(3) A handful of mutations are found at low frequencies
inoverhalf of thecountriesstudied.TheseincludeIVSII-745
(C>G), a mutation of Mediterranean origin, detected
solely in Mediterranean Arab countries, and found at its
highest frequency in North Jordan (12%); Cd6( −A),another
Mediterranean mutation found mostly in North African
Arab countries (10%–17%) and at a lower frequency in
Gaza and Saudi Arabia. Cd8( −AA) is a mutation of Turkish
origin found at more or less the same low frequency, except
in Saudi Arabia, where it reaches 10%. Two Asian-Indian
mutations, Cd8/9 (+G) and the 25bp deletion are found
at low frequency in some countries but reach their highest
frequencies in countries of the Arabian Peninsula. In fact,
the 25bp deletion is the most frequent mutation in Bahrain
(36%). Cd44 (−C) is a mutation of Kurdish origin detected
mostly in countries of the Arabian Peninsula (up to 10% in
Oman), but also in Lebanon (1%) and Tunisia (4%). Cd37
(G>A) is a mutation mostly encountered in Jordan (9%) and
among Israeli Arabs (7%).
(4) Six mutations were detected in more than two Arab
countries. These include the T>A substitution at −30,amu-
tationof Turkishorigin,detectedonlyinMediterraneanArab
countries, Cd15 (G>A), an Asian Indian mutation, clustered
around countries of the Gulf, but also found in Syria and
Israeli Arabs; the substitution at −87 (C>G) is of Mediter-
ranean origin and thus found in 4 mediterranean coun-
tries. Cd27 (C>T) and IVSII-848 (C>A) are found mostly
in Northern African Arab countries, with some patients
reported in Jordan. Cd27 is also known as Hb Knossos,
reported around the Mediterranean, while IVSII-848 is of
Egyptian origin, which explains its highest frequency there
(9%). The frameshift mutation at Cd36/37 (−T) is reported
only from countries in the Arabian Peninsula. This Kur-
dish/Iranian mutation is quite frequent in Saudi Arabia,
where it represents 12% of the alleles studied. The substi-
tution at Cd30 (G>A) is reportedly of Bulgarian origin and
was detected mostly in Tunisia and Algeria (1%–3%).
(5) Some rare mutations were reported in two countries,
whichgenerallytendtobeneighboringcountries.Thisistrue
of −88(C>T),amutationofAsian-Indianorigin,reportedin
SyriaandLebanon,Cd37(−G),ofKurdishorigin,reportedin
Oman and the UAE, IVSI-2 (T>A) and IVSI-5 (G>A), both
of Algerianorigin,reportedinTunisiaandAlgeria.AnAsian-
Indian mutation, Cap +1 (A>C) and a Kurdish mutation,
−88(C>A)werebothreportedfromacountryintheArabian
Peninsula and Egypt. Cd30 (G>C), of UAE origin, was also
detected at the same frequency in Lebanon (3%).
(6)SomemutationswereexclusivelydetectedinoneArab
country.Someof thesearebelievedtohaveoriginatedspecif-
ically there, while others have been previously reported at
higher frequencies in other countries. In the ﬁrst case, one
can notably mention the Lebanese mutation, Cd29 (C>T)
found in 7% of alleles; a 6bp deletion in the poly-A tail, de-
tected in the population of the Gaza strip; and Hb Dofar,
detected in 7% of the alleles studied in Oman. Six other mu-
tations have an exclusive origin in their reported country,
and have, so far, not been identiﬁed elsewhere. Other mu-
tations, although identiﬁed in a single Arab country, were
previously seen in other populations. These include, for in-
stance, the 290bp deletion of Iranian/Turkish origin, rep-
resenting 2% of alleles in Lebanon; Cd35 (−C) of Indone-
sian origin and Cd41/42 (−TCTT) of Asian-Indian origin
reported in Bahrain (1.5% both); Cd110 (T>C) of Japanese
origin,foundintheUAE(0.8%);the619bpdeletionofIndian
origin, reported in 4% of alleles in Oman; Cd106/107 (+G),
a mutation of BlackAmerican origin,identiﬁed in Egypt and
−29 (A>C), another Black American mutation detected in
Algeria only.
DISCUSSION
The Arab countries encompass a wide region including
Northern Africa, the Nile valley, Western Asia and the Ara-
bian Peninsula. In addition to geographic differences, each
country has experienced admixtures from various popula-
tions throughout history. Furthermore, migration between
Arab countries has been common until the present times.
The heterogeneity of theArab people is reﬂected in the 52 β-
thalassemia mutations detected. These mutations are mainly
ofMediterraneanandAsianorigin,and,althoughsomecoun-
tries have unique mutations, no speciﬁc mutation seems to
be conﬁned to the Arabs.
The most widespread and common mutations are pre-
sumably the oldest. This is true of Codon 39 and IVSI-110.
Cd39, which is believed to be of Roman origin, is most fre-
quent in the Western Mediterranean Arab countries and de-
creasesinfrequencytowardstheEast.However,thismutation
also reaches a high frequency in some countries of the Ara-
bian Peninsula,a fact that may be explained by gene ﬂow and
founder effect. IVSI-110, which is believed to have arisen in
Turkey,reachesitshighestfrequenciesintheEasternMediter-
ranean Arab countries, and may have been introduced to
othercountriesbyavarietyofsettlersfromtheEast,including
Turks, Greeks, or Phoenicians.
The most frequent and widespread Asian-Indian muta-
tion in Arab countries is IVSI-5 (G>C). As expected, its fre-
quencyishighestincountriesof theArabianPeninsula,while
its lower frequency in Western Asian Arab countries may be
explained by migration. This mutation is practically nonex-
istent in Northern Africa. However, the mutation in Arabs is
foundonaβ-globinhaplotypedistinctfromtheAsian-Indian
one,and is therefore believed to have an independent origin.
In general, the distribution of the other mutations, as
expected, reﬂects the geographical location of each coun-132 Laila Zahed 1:3 (2001)
try. Mutations of Mediterranean origin tend to be found
at higher frequencies around the Mediterranean Arab coun-
tries, whereas Asian-Indian mutations tend to be clustered
around countries closer to the Indian subcontinent. How-
ever, population migration may explain the ﬂow of some of
these mutations towards other distant countries. The same
applies for some rare mutations:Arab countries of Northern
Africa also have an admixture of some African Black mu-
tations, while some Kurdish or Iranian mutations are often
detected in countries of the Arabian Peninsula and Western
Asia.Ineachcountry,thespectrumofmutationscouldbewell
explainedbylookingatitsgeographicallocationanditsindi-
vidualhistoryofwars,invasions,migrations,andsettlements.
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